A debate has begun on the application of federal drug laws to assisted suicide -- a debate which may result in a new federal law to counter Oregon's experiment in doctor-assisted death. Last November the Drug Enforcement Administration (DEA) concluded that assisting a suicide is not a "legitimate medical purpose" for the use of federally regulated drugs, and that using such drugs to assist a suicide could cost a physician the federal DEA registration authorizing him or her to prescribe controlled substances. But on June 5, U.S. attorney general Janet Reno reversed the DEA policy, ruling th…
